ProfileGDS4718 / 238774_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 67% 45% 31% 41% 56% 35% 33% 22% 39% 50% 48% 61% 29% 36% 34% 45% 34% 43% 43% 62% 38% 39% 33% 47% 56% 42% 54% 64% 65% 40% 23% 28% 39% 44% 38% 31% 38% 35% 33% 18% 39% 52% 43% 38% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.5961167
GSM549102patient 115, normal, homogenized [OPG study]5.2540145
GSM549104patient 119, normal, homogenized [OPG study]4.5859231
GSM549108patient 138, normal, homogenized [OPG study]5.099441
GSM549119patient 077, normal, homogenized [OPG study]5.8723456
GSM549133patient 032, cancer, homogenized [OPG study]4.7172335
GSM549139patient 042, cancer, homogenized [OPG study]4.6698733
GSM549099patient 107, normal, homogenized [OPG study]4.2235522
GSM549109patient 139, normal, homogenized [OPG study]4.954239
GSM549110patient 046, normal, homogenized [OPG study]5.5382450
GSM549114patient 063, normal, homogenized [OPG study]5.3521548
GSM549122patient 082, normal, homogenized [OPG study]6.1911261
GSM549134patient 033, cancer, homogenized [OPG study]4.4866829
GSM549136patient 036, cancer, homogenized [OPG study]4.7463936
GSM549140patient 044, cancer, homogenized [OPG study]4.6769734
GSM549111patient 047, normal, homogenized [OPG study]5.2128645
GSM549113patient 057, normal, homogenized [OPG study]4.644334
GSM549132patient 031, cancer, homogenized [OPG study]5.1395443
GSM549137patient 038, cancer, homogenized [OPG study]5.1098343
GSM549142patient 047, cancer, homogenized [OPG study]6.3095762
GSM549100patient 110, normal, homogenized [OPG study]4.9217738
GSM549107patient 135, normal, homogenized [OPG study]4.9160739
GSM549115patient 068, normal, homogenized [OPG study]4.6062633
GSM549116patient 072, normal, homogenized [OPG study]5.3038347
GSM549120patient 078, normal, homogenized [OPG study]5.8389256
GSM549131patient 030, cancer, homogenized [OPG study]5.0238842
GSM549118patient 074, normal, homogenized [OPG study]5.7647354
GSM549129patient 027, cancer, homogenized [OPG study]6.4184764
GSM549123patient 088, normal, homogenized [OPG study]6.4957165
GSM549124patient 006, cancer, homogenized [OPG study]5.0268840
GSM549126patient 015, cancer, homogenized [OPG study]4.2382423
GSM549128patient 025, cancer, homogenized [OPG study]4.4558328
GSM549103patient 117, normal, homogenized [OPG study]5.021539
GSM549117patient 073, normal, homogenized [OPG study]5.1724344
GSM549138patient 041, cancer, homogenized [OPG study]4.8924538
GSM549141patient 045, cancer, homogenized [OPG study]4.5123931
GSM549130patient 028, cancer, homogenized [OPG study]4.9092838
GSM549101patient 111, normal, homogenized [OPG study]4.7860135
GSM549105patient 128, normal, homogenized [OPG study]4.6846833
GSM549106patient 134, normal, homogenized [OPG study]4.0325518
GSM549112patient 048, normal, homogenized [OPG study]4.9446639
GSM549125patient 011, cancer, homogenized [OPG study]5.6460452
GSM549127patient 024, cancer, homogenized [OPG study]5.153543
GSM549135patient 035, cancer, homogenized [OPG study]4.855638